41

Yung Zip Chemical Ind Co Ltd

4102 · TWO · Healthcare / Drug Manufacturers - General

17.50TWD-0.05 (-0.28%)

Price History

Full chart

Market Stats

Previous Close17.55
Open17.55
Day Range17.45 – 17.60
52-Week Range16.50 – 23.55
Volume21.96K
Market Cap781.80M
P/E (TTM)0.00
Forward P/E15.90
EPS-0.02
Dividend Yield0.00%
Beta-0.07
50-Day Avg18.96
200-Day Avg19.21

About

Yung Zip Chemical Ind. Co., Ltd., together with its subsidiaries, engages in the manufacturing and trading of active pharmaceutical ingredients in Taiwan, China, Asia, the Americas, and internationally. The company offers active pharmaceutical ingredients and excipients, API intermediates, and specialty chemicals. It is also involved in custom research and manufacturing services; general investments; and food manufacturing. The company was founded in 1978 and is based in Taichung, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOChing Hwang Lin
  • Employees181
  • HeadquartersNo. 59 and 61, You Shih Road, Taichung, Taiwan, 437, Taiwan
  • Websitehttps://www.yungzip.com

Leadership

  • Ching Hwang LinChairman & President
  • Yufang WangAccounting Supervisor

Financials

Income Statement

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue230.24M269.93M278.57M264.18M290.16M280.55M278.35M432.77M528.41M451.47M431.57M300.38M277.48M317.57M268.09M314.37M357.09M416.84M463.21M477.60M567.33M559.15M583.70M474.22M
Growth (%)-+17.24%+3.20%-5.16%+9.83%-3.31%-0.79%+55.48%+22.10%-14.56%-4.41%-30.40%-7.62%+14.45%-15.58%+17.26%+13.59%+16.73%+11.13%+3.11%+18.79%-1.44%+4.39%-18.76%
Cost of Revenue119.82M155.84M143.53M140.80M161.85M175.43M174.91M201.77M255.80M234.71M267.53M215.39M216.32M266.57M266.04M252.51M296.18M300.11M328.30M373.09M402.36M385.26M405.30M379.65M
Gross Profit-------------51.00M2.05M61.86M60.91M116.73M134.91M104.51M164.97M173.89M178.40M94.57M
Gross Margin-------------16.06%0.77%19.68%17.06%28.00%29.13%21.88%29.08%31.10%30.56%19.94%
Operating Expense-------------82.11M72.34M82.56M82.74M94.81M104.66M95.07M86.22M102.82M117.05M114.39M
Operating Income27.43M7.94M17.39M16.27M15.19M4.03M1.24M92.20M120.39M77.12M----31.11M-70.29M-20.70M-21.82M21.93M30.25M9.44M78.75M71.07M61.35M-19.82M
Operating Margin11.91%2.94%6.24%6.16%5.24%1.44%0.44%21.30%22.78%17.08%----9.80%-26.22%-6.58%-6.11%5.26%6.53%1.98%13.88%12.71%10.51%-4.18%
EBITDA---------------31.93M33.94M72.03M68.07M49.84M117.16M106.58M113.72M28.21M
EBITDA Margin---------------10.16%9.50%17.28%14.69%10.44%20.65%19.06%19.48%5.95%
Net Income16.30M7.36M10.65M17.49M18.64M6.73M-74.87M105.24M81.85M3.49M---27.65M-68.33M-24.96M-14.96M31.32M30.74M6.00M69.99M62.51M64.61M-14.36M
Net Income Margin7.08%2.73%3.82%6.62%6.42%2.40%-17.30%19.92%18.13%0.81%---8.71%-25.49%-7.94%-4.19%7.51%6.64%1.26%12.34%11.18%11.07%-3.03%
R&D13.06M23.75M27.13M18.36M27.54M22.41M18.97M27.74M39.38M25.70M45.56M31.49M24.55M28.49M22.32M23.62M26.49M31.11M32.97M31.23M34.94M34.14M32.80M32.12M
R&D as % of Total Revenue5.67%8.80%9.74%6.95%9.49%7.99%6.81%6.41%7.45%5.69%10.56%10.48%8.85%8.97%8.33%7.51%7.42%7.46%7.12%6.54%6.16%6.10%5.62%6.77%
Interest Expense0000000000000000885.00K892.00K1.90M2.63M3.19M3.34M2.15M1.90M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.25%0.21%0.41%0.55%0.56%0.60%0.37%0.40%

Balance Sheet

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets550.57M581.99M546.34M507.71M521.84M532.84M518.12M593.47M732.05M944.18M806.84M714.59M663.92M646.53M553.57M551.14M613.39M685.20M953.56M930.25M1.03B990.27M964.63M924.11M
Total Liabilities65.49M110.91M79.12M44.83M53.97M75.66M93.39M110.95M119.22M138.54M74.23M77.02M93.89M126.13M99.92M121.94M167.34M184.84M381.32M353.87M345.94M282.49M222.61M256.81M
Total Equity485.08M471.08M467.22M462.88M467.87M457.18M424.72M482.52M612.82M805.64M732.61M637.57M570.03M520.40M453.65M429.19M446.05M500.37M512.02M514.11M613.57M635.58M664.37M588.26M
Cash43.34M94.20M34.89M20.94M40.85M30.21M23.32M73.88M175.12M193.81M80.76M54.02M52.21M43.13M44.02M29.67M40.16M53.13M53.41M78.20M144.18M124.11M133.53M95.04M
Total Debt------------------258.61M252.59M214.29M152.29M--
Net Debt---------------30.33M36.14M3.12M205.20M174.38M70.11M28.18M-57.02M

Cash Flow

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow31.98M70.09M41.38M32.66M61.64M5.38M45.02M163.08M168.59M45.51M100.80M25.94M-5.36M19.54M-15.85M15.45M30.76M36.07M73.27M92.55M96.76M118.67M-4.04M
Investing Cash Flow---10.52M----------21.72M-18.65M-18.50M-19.96M-16.17M-174.67M-35.34M16.80M---
Financing Cash Flow-10.60M---445.00K--29.01M145.41M--20.00M7.29M20.00M20.00M15.00M-1.61M138.88M-13.13M-44.34M-97.36M--
Capital Expenditure44.34M30.59M36.33M15.40M28.53M17.74M42.75M53.74M95.21M171.03M96.95M24.05M7.89M22.34M16.77M18.50M15.47M14.67M39.38M27.17M26.16M27.45M38.51M42.13M
Free Cash Flow----------------34.35M-3.42M16.09M-3.31M46.09M66.40M69.31M80.17M-46.18M
Dividends Paid16.53M14.67M16.53M16.52M16.45M16.52M16.52M16.52M33.05M60.53M76.27M12.71M-12.71M--4.24M4.24M4.24M4.24M4.24M33.90M33.90M51.64M
FCF to OCF---------------216.68%-22.12%52.30%-9.19%62.91%71.74%71.63%67.55%1142.40%
Dividend Paid to FCF-----------------123.96%26.34%-127.81%9.19%6.38%48.91%42.29%-111.82%

Earnings

Report DateOct 29, 2009Apr 29, 2010Oct 28, 2010Jan 15, 2011Apr 15, 2011Aug 28, 2011Nov 15, 2019Mar 11, 2020May 5, 2020Aug 5, 2020Nov 9, 2020May 6, 2021Aug 6, 2021Nov 5, 2021Mar 3, 2022May 5, 2022Aug 5, 2022Nov 7, 2022Mar 7, 2023
EPS Estimate0.490.680.630.790.730.670.280.270.310.270.25--------
EPS Actual0.450.311.020.230.310.390.130.160.410.23-0.09-0.070.29-0.120.050.120.790.250.49
Surprise-8.16%-54.41%61.90%-70.89%-57.53%-41.79%-53.57%-40.74%32.26%-14.81%-136.00%--------
TimingPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap781.80M
Enterprise Value865.81M
Trailing P/E0.00
Forward P/E15.90
Price / Sales1.58
Price / Book1.32
EPS-0.02
Book Value14.14
Revenue (TTM)494.04M
Gross Profit (TTM)103.03M
EBITDA22.08M
Profit Margin-0.11%
Operating Margin2.37%
Return on Equity0.56%
Return on Assets-0.97%
Shares Outstanding42.37M
Shares Float31.02M
Beta-0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
1.15Jul 4, 2025
20241×
0.80Jul 4, 2024
20231×
0.80Jul 4, 2023
20221×
0.10Jul 5, 2022
20211×
0.10Aug 18, 2021
20151×
0.30Jul 14, 2015
20131×
0.30Jul 18, 2013
20121×
1.80Jul 19, 2012
20111×
1.43Aug 4, 2011
20101×
0.95Aug 16, 2010
20091×
0.48Jul 15, 2009
20081×
0.48Jul 15, 2008

Stock Splits

  • Aug 4, 20111.05:1